Paper34636151
Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis.
Suzuki E and 11 others. Int J Rheum Dis, 2021. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis. Papers, record 34636151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34636151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lupus Nephritis | Major topic |
| Remission Induction | Major topic |
| Adult | |
| Disease Progression | |
| Female | |
| Humans | |
| Immunosuppressive Agents | |
| Male | |
| Recurrence | |
| Retrospective Studies | |
| Risk Factors | |
| Time Factors |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27821390 | Update on Lupus Nephritis. | Clin J Am Soc Nephrol | 2017 | https://conductscience.org/library/papers/27821390 | PubMed |
| 2 | 19369404 | Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. | J Am Soc Nephrol | 2009 | https://conductscience.org/library/papers/19369404 | PubMed |
| 3 | 25018937 | Chapter 12: Lupus nephritis. | Kidney Int Suppl (2011) | 2012 | https://conductscience.org/library/papers/25018937 | PubMed |
| 4 | 12079714 | Demographic differences in the development of lupus nephritis: a retrospective analysis. | Am J Med | 2002 | https://conductscience.org/library/papers/12079714 | PubMed |
| 5 | 14717922 | The classification of glomerulonephritis in systemic lupus erythematosus revisited. | Kidney Int | 2004 | https://conductscience.org/library/papers/14717922 | PubMed |
| 6 | 22556106 | American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. | Arthritis Care Res (Hoboken) | 2012 | https://conductscience.org/library/papers/22556106 | PubMed |
| 7 | 25563691 | Early achievement of complete renal response predicts good long-term renal outcome and low systemic damage in newly diagnosed lupus nephritis class III or IV. | Mod Rheumatol | 2015 | https://conductscience.org/library/papers/25563691 | PubMed |
| 8 | 22129255 | Systemic lupus erythematosus. | N Engl J Med | 2011 | https://conductscience.org/library/papers/22129255 | PubMed |
| 9 | 30442061 | Late-onset biopsy-proven lupus nephritis without other associated autoimmune diseases: severity and long-term outcome. | Lupus | 2019 | https://conductscience.org/library/papers/30442061 | PubMed |
| 10 | 30926722 | 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. | Ann Rheum Dis | 2019 | https://conductscience.org/library/papers/30926722 | PubMed |
| 11 | 22052624 | Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. | Arthritis Care Res (Hoboken) | 2012 | https://conductscience.org/library/papers/22052624 | PubMed |
| 12 | 31180030 | Management strategies and future directions for systemic lupus erythematosus in adults. | Lancet | 2019 | https://conductscience.org/library/papers/31180030 | PubMed |
| 13 | 15334470 | Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. | Arthritis Rheum | 2004 | https://conductscience.org/library/papers/15334470 | PubMed |
| 14 | 14747370 | The classification of glomerulonephritis in systemic lupus erythematosus revisited. | J Am Soc Nephrol | 2004 | https://conductscience.org/library/papers/14747370 | PubMed |
| 15 | 31296139 | Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan. | Lupus | 2019 | https://conductscience.org/library/papers/31296139 | PubMed |
| 16 | 29314776 | Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis. | Int J Rheum Dis | 2018 | https://conductscience.org/library/papers/29314776 | PubMed |
| 17 | 18413438 | Delayed lupus nephritis. | Ann Rheum Dis | 2008 | https://conductscience.org/library/papers/18413438 | PubMed |
| 18 | 22851469 | Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. | Ann Rheum Dis | 2012 | https://conductscience.org/library/papers/22851469 | PubMed |
| 19 | 9324032 | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. | Arthritis Rheum | 1997 | https://conductscience.org/library/papers/9324032 | PubMed |
| 20 | 18003764 | Value of a complete or partial remission in severe lupus nephritis. | Clin J Am Soc Nephrol | 2008 | https://conductscience.org/library/papers/18003764 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38648778 | Risk of chronic kidney disease in 260 patients with lupus nephritis: analysis of a nationwide multicentre cohort with up to 35 years of follow-up. | Rheumatology (Oxford) | 2025 | https://conductscience.org/library/papers/38648778 | PubMed |
| 38247126 | Predictors of renal relapse in Koreans with lupus nephritis after achieving complete response: a 35-years of experience at a single center. | Korean J Intern Med | 2024 | https://conductscience.org/library/papers/38247126 | PubMed |
| 34636151 | Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis. | Int J Rheum Dis | 2021 | https://conductscience.org/library/papers/34636151 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34636151
GET https://conductscience.org/api/papers/v1/34636151/references?page=2